Throughout the last three months, 4 analysts have evaluated Omega Therapeutics (NASDAQ:OMGA), offering a diverse set of opinions from bullish to bearish. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Analysts have set 12-month price targets for Omega Therapeutics, revealing an average target of $10.5, a high estimate of $12.00, and a low estimate of $6.00. This current average reflects an increase of 1.65% from the previous average price target of $10.33. Exploring Analyst Ra…